LifeVantage (NASDAQ:LFVN) Issues FY 2020 After-Hours Earnings Guidance

LifeVantage (NASDAQ:LFVN) issued an update on its FY 2020
After-Hours earnings guidance on Tuesday morning. The company provided EPS guidance of 0.74-0.79 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.70. The company issued revenue guidance of $235-245 million, compared to the consensus revenue estimate of $245 million.

LFVN stock traded up $1.69 during trading on Wednesday, hitting $16.74. 18,618 shares of the company’s stock traded hands, compared to its average volume of 72,216. The company has a quick ratio of 1.09, a current ratio of 1.67 and a debt-to-equity ratio of 0.02. LifeVantage has a 52 week low of $10.62 and a 52 week high of $16.34. The stock has a fifty day moving average price of $15.53 and a two-hundred day moving average price of $13.77. The stock has a market capitalization of $222.14 million, a price-to-earnings ratio of 29.63 and a beta of 0.64.

LifeVantage (NASDAQ:LFVN) last released its earnings results on Tuesday, January 28th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.15. LifeVantage had a net margin of 3.65% and a return on equity of 38.13%. The firm had revenue of $61.24 million during the quarter. As a group, equities research analysts expect that LifeVantage will post 0.67 EPS for the current fiscal year.

Separately, ValuEngine raised shares of LifeVantage from a sell rating to a hold rating in a report on Tuesday, December 3rd.

In other news, CEO Darren Jay Jensen sold 4,500 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $14.13, for a total transaction of $63,585.00. Following the completion of the transaction, the chief executive officer now owns 411,470 shares of the company’s stock, valued at $5,814,071.10. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last three months, insiders have sold 13,500 shares of company stock valued at $203,805. Corporate insiders own 6.80% of the company’s stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Further Reading: What is a recession?

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit